9th European Multidisciplinary Meeting on Urological Cancers
Barcelona, Spain, will host from 16 to 19 November 2017, the 9th European Multidisciplinary Meeting on Urological Cancers (EMUC17), one of Europe’s well-attended international conferences for multidisciplinary specialists with expertise in urological malignancies.
EMUC17 pursues the goals of earlier editions where critical insights on current and prospective treatment strategies will be discussed by leading experts and opinion leaders with special focus on best practices, achieving consensus on controversial issues and applying the outcomes of translational research.
Organisers of the EMUC draw from the collaborative efforts and resources of the European Society for Medical Oncology (ESMO), the European SocieTy for Radiotherapy & Oncology (ESTRO) and the European Association of Urology (EAU). The collaboration not only offers an annual platform for scientific discussions that address emerging trends in urological cancers, but also links up various specialists and stakeholders in their common aim to achieve quality healthcare.
Affiliated organisations such as the European School of Urology (ESU) with ESU courses on Renal and Bladder Cancer and the EAU Section of Urological Imaging (ESUI) provide vital support to the event and widen the coverage of the Scientific Programme. Additionally, the EAU Prostate Cancer Centre Consesus Meeting (EPCCCM) will be held to define the criteria for a European Prostate Cancer Centre.
From identifying forward-thinking approaches, discussing gaps in current treatment to improving standard medical protocols, the EMUC strives to achieve efficient multidisciplinary collaboration. After nearly a decade, participants of previous EMUC events have lauded EMUC’s role in anticipating key developments which enable cancer experts to tackle future challenges.
Join us in Barcelona in 2017 for another quality scientific exchange!
Informed Viewpoints Across Disciplines
EMUC gathers medical oncologists, radiologists, pathologists and urologists to share knowledge and expertise. In four days, the latest developments in treating urological cancers are carefully evaluated and insights presented.
Experts and Opinion Leaders
Opinion leaders and uro-oncology experts will lead plenary sessions, debates and panel discussions and present lectures that cast a critical eye on dilemmas in everyday clinical practice.
Participants benefit from a discounted fee when they register for both EMUC17 and ESUI17 events!